Capital Fund Management S.A. Nevro Corp Transaction History

Capital Fund Management S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$22.62 - $39.32 $277,977 - $483,203	-12,289 Reduced 7.12%	160,222 $4.07 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $401,291 - $546,804	13,301 Added 8.35%	172,511 $6.24 Million
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $1.75 Million - $2.38 Million	48,163 Added 43.37%	159,210 $6.3 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $179,961 - $234,710	4,426 Added 4.15%	111,047 $5.17 Billion
Q2 2022 Aug 12, 2022	BUY	$40.85 - $77.67 $1.98 Million - $3.77 Million	48,546 Added 83.59%	106,621 $4.67 Million
Q1 2022 May 12, 2022	BUY	$59.95 - $92.06 $3.48 Million - $5.35 Million	58,075 New	58,075 $4.2 Million
Q1 2020 May 13, 2020	SELL	$70.23 - $144.31 $252,828 - $519,516	-3,600 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$76.41 - $117.54 $275,076 - $423,144	3,600 New	3,600 $423,000
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $2.1 Million - $2.67 Million	-30,200 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$65.94 - $93.31 $1.99 Million - $2.82 Million	30,200	30,200 $2.09 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.